BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weymann D, Laskin J, Roscoe R, Schrader KA, Chia S, Yip S, Cheung WY, Gelmon KA, Karsan A, Renouf DJ, Marra M, Regier DA. The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers. Mol Genet Genomic Med 2017;5:251-60. [PMID: 28546995 DOI: 10.1002/mgg3.281] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Oliveira AG, Fiorotto R. Novel approaches to liver disease diagnosis and modeling. Transl Gastroenterol Hepatol 2021;6:19. [PMID: 33824923 DOI: 10.21037/tgh-20-109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Schwarze K, Buchanan J, Fermont JM, Dreau H, Tilley MW, Taylor JM, Antoniou P, Knight SJL, Camps C, Pentony MM, Kvikstad EM, Harris S, Popitsch N, Pagnamenta AT, Schuh A, Taylor JC, Wordsworth S. The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom. Genet Med 2020;22:85-94. [PMID: 31358947 DOI: 10.1038/s41436-019-0618-7] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 14.0] [Reference Citation Analysis]
3 Palmieri G, Rozzo CM, Colombino M, Casula M, Sini MC, Manca A, Pisano M, Doneddu V, Paliogiannis P, Cossu A. Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? Front Oncol 2021;11:666624. [PMID: 34026645 DOI: 10.3389/fonc.2021.666624] [Reference Citation Analysis]
4 Vetsch J, Wakefield CE, Techakesari P, Warby M, Ziegler DS, O'Brien TA, Drinkwater C, Neeman N, Tucker K. Healthcare professionals' attitudes toward cancer precision medicine: A systematic review. Semin Oncol 2019;46:291-303. [PMID: 31221444 DOI: 10.1053/j.seminoncol.2019.05.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Gong J, Pan K, Fakih M, Pal S, Salgia R. Value-based genomics. Oncotarget 2018;9:15792-815. [PMID: 29644010 DOI: 10.18632/oncotarget.24353] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
6 Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med 2018;20:1122-30. [PMID: 29446766 DOI: 10.1038/gim.2017.247] [Cited by in Crossref: 197] [Cited by in F6Publishing: 171] [Article Influence: 49.3] [Reference Citation Analysis]
7 McBride CM. Translation research to apply genomics to improve health promotion: Is it worth the investment? Transl Behav Med 2018;8:54-8. [PMID: 29385586 DOI: 10.1093/tbm/ibx051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Weymann D, Dragojlovic N, Pollard S, Regier DA. Allocating healthcare resources to genomic testing in Canada: latest evidence and current challenges. J Community Genet 2019. [PMID: 31273679 DOI: 10.1007/s12687-019-00428-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fahim A. Retinitis pigmentosa: recent advances and future directions in diagnosis and management. Current Opinion in Pediatrics 2018;30:725-33. [DOI: 10.1097/mop.0000000000000690] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
10 Shajii A, Numanagić I, Baghdadi R, Berger B, Amarasinghe S. Seq: a high-performance language for bioinformatics. Proc ACM Program Lang 2019;3:1-29. [DOI: 10.1145/3360551] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
11 Payne K, Gavan SP, Wright SJ, Thompson AJ. Cost-effectiveness analyses of genetic and genomic diagnostic tests. Nat Rev Genet 2018;19:235-46. [PMID: 29353875 DOI: 10.1038/nrg.2017.108] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 13.8] [Reference Citation Analysis]
12 Dragojlovic N, Elliott AM, Adam S, van Karnebeek C, Lehman A, Mwenifumbo JC, Nelson TN, du Souich C, Friedman JM, Lynd LD. The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study. Genet Med 2018;20:1013-21. [PMID: 29300375 DOI: 10.1038/gim.2017.226] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 11.3] [Reference Citation Analysis]
13 van de Ven M, Koffijberg H, Retèl V, Monkhorst K, Smit E, van Harten W, IJzerman M. Real-World Utilization of Biomarker Testing for Patients with Advanced Non-Small Cell Lung Cancer in a Tertiary Referral Center and Referring Hospitals. J Mol Diagn 2021;23:484-94. [PMID: 33493663 DOI: 10.1016/j.jmoldx.2021.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Weymann D, Laskin J, Jones SJM, Roscoe R, Lim HJ, Renouf DJ, Schrader KA, Sun S, Yip S, Marra MA, Regier DA. Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care. J Community Genet 2021. [PMID: 34843087 DOI: 10.1007/s12687-021-00557-w] [Reference Citation Analysis]
15 Ghani M, Nfonsam L, Pranckeviciene E, Daoud H, Potter R, Chisholm C, Harper PE, Schaffer A, Little L, Sinclair-Bourque E, McGowan-Jordan J, Smith A, Bronicki L, Jarinova O. Adopting High-Resolution Allele Frequencies Substantially Expedites Variant Interpretation in Genetic Diagnostic Laboratories. J Mol Diagn 2019;21:602-11. [PMID: 31028938 DOI: 10.1016/j.jmoldx.2019.02.009] [Reference Citation Analysis]
16 Ordelheide AM, Hrabě de Angelis M, Häring HU, Staiger H. Pharmacogenetics of oral antidiabetic therapy. Pharmacogenomics 2018;19:577-87. [PMID: 29580198 DOI: 10.2217/pgs-2017-0195] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kutnjak D, Tamisier L, Adams I, Boonham N, Candresse T, Chiumenti M, De Jonghe K, Kreuze JF, Lefebvre M, Silva G, Malapi-Wight M, Margaria P, Mavrič Pleško I, McGreig S, Miozzi L, Remenant B, Reynard JS, Rollin J, Rott M, Schumpp O, Massart S, Haegeman A. A Primer on the Analysis of High-Throughput Sequencing Data for Detection of Plant Viruses. Microorganisms 2021;9:841. [PMID: 33920047 DOI: 10.3390/microorganisms9040841] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Bertier G, Joly Y. Clinical exome sequencing in France and Quebec: what are the challenges? What does the future hold? Life Sci Soc Policy 2018;14:17. [PMID: 30066179 DOI: 10.1186/s40504-018-0081-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Ferrari RG, Panzenhagen PHN, Conte-Junior CA. Phenotypic and Genotypic Eligible Methods for Salmonella Typhimurium Source Tracking. Front Microbiol 2017;8:2587. [PMID: 29312260 DOI: 10.3389/fmicb.2017.02587] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
20 Popa O, Oldenburg E, Ebenhöh O. From sequence to information. Philos Trans R Soc Lond B Biol Sci 2020;375:20190448. [PMID: 33131436 DOI: 10.1098/rstb.2019.0448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Roos A, Byron SA. Genomics-Enabled Precision Medicine for Cancer. Cancer Treat Res 2019;178:137-69. [PMID: 31209844 DOI: 10.1007/978-3-030-16391-4_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
22 Phillips KA, Deverka PA, Marshall DA, Wordsworth S, Regier DA, Christensen KD, Buchanan J. Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions. Value Health 2018;21:1033-42. [PMID: 30224106 DOI: 10.1016/j.jval.2018.06.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
23 Oboh MA, Omoleke SA, Ajibola O, Manneh J, Kanteh A, Sesay AK, Amambua-Ngwa A. Translation of genomic epidemiology of infectious pathogens: Enhancing African genomics hubs for outbreaks. Int J Infect Dis 2020;99:449-51. [PMID: 32800861 DOI: 10.1016/j.ijid.2020.08.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Gordon LG, White NM, Elliott TM, Nones K, Beckhouse AG, Rodriguez-Acevedo AJ, Webb PM, Lee XJ, Graves N, Schofield DJ. Estimating the costs of genomic sequencing in cancer control. BMC Health Serv Res 2020;20:492. [PMID: 32493298 DOI: 10.1186/s12913-020-05318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Gabaldón T; Consortium OPATHY. Recent trends in molecular diagnostics of yeast infections: from PCR to NGS. FEMS Microbiol Rev 2019;43:517-47. [PMID: 31158289 DOI: 10.1093/femsre/fuz015] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
26 Lee JJY, van Karnebeek CDM, Wasserman WW. Development and user evaluation of a rare disease gene prioritization workflow based on cognitive ergonomics. J Am Med Inform Assoc 2019;26:124-33. [PMID: 30535356 DOI: 10.1093/jamia/ocy153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]